niclosamide has been researched along with Atherogenesis in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navab, M | 1 |
| Ruchala, P | 1 |
| Waring, AJ | 1 |
| Lehrer, RI | 1 |
| Hama, S | 1 |
| Hough, G | 1 |
| Palgunachari, MN | 1 |
| Anantharamaiah, GM | 1 |
| Fogelman, AM | 1 |
1 other study available for niclosamide and Atherogenesis
| Article | Year |
|---|---|
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Ap | 2009 |